Analysts’ Updated EPS Estimates for August 7th (AMGN, BCYC, CART, CSX, DDOG, EXPD, GBDC, IMVT, KVUE, LCII)

Analysts’ updated eps estimates for Wednesday, August 7th:

Amgen (NASDAQ:AMGN) had its outperform rating reissued by analysts at Oppenheimer Holdings Inc.. They currently have a $380.00 price target on the stock.

Amgen (NASDAQ:AMGN) had its hold rating reiterated by analysts at Deutsche Bank Aktiengesellschaft. The firm currently has a $305.00 price target on the stock, down from their previous price target of $310.00.

Bicycle Therapeutics (NASDAQ:BCYC) had its outperform rating reissued by analysts at Oppenheimer Holdings Inc.. They currently have a $48.00 price target on the stock.

Maplebear (NASDAQ:CART) had its hold rating reissued by analysts at Benchmark Co..

CSX (NASDAQ:CSX) had its buy rating reissued by analysts at Benchmark Co.. They currently have a $40.00 target price on the stock.

Datadog (NASDAQ:DDOG) was upgraded by analysts at Monness Crespi & Hardt from a sell rating to a neutral rating.

Expeditors International of Washington (NASDAQ:EXPD) had its hold rating reissued by analysts at Benchmark Co..

Golub Capital BDC (NASDAQ:GBDC) had its outperform rating reissued by analysts at Oppenheimer Holdings Inc.. The firm currently has a $17.00 price target on the stock.

Immunovant (NASDAQ:IMVT) had its overweight rating reissued by analysts at Cantor Fitzgerald.

Kenvue (NYSE:KVUE) had its outperform rating reiterated by analysts at Royal Bank of Canada. They currently have a $24.00 target price on the stock.

LCI Industries (NYSE:LCII) had its buy rating reiterated by analysts at Benchmark Co.. They currently have a $130.00 target price on the stock.

Ligand Pharmaceuticals (NASDAQ:LGND) had its outperform rating reaffirmed by analysts at Royal Bank of Canada. They currently have a $130.00 target price on the stock.

Owens Corning (NYSE:OC) had its hold rating reiterated by analysts at Benchmark Co..

Olema Pharmaceuticals (NASDAQ:OLMA) had its outperform rating reiterated by analysts at Oppenheimer Holdings Inc.. Oppenheimer Holdings Inc. currently has a $30.00 target price on the stock.

Permian Resources (NASDAQ:PR) had its buy rating reaffirmed by analysts at Benchmark Co.. Benchmark Co. currently has a $17.00 price target on the stock.

Qualys (NASDAQ:QLYS) had its market perform rating reaffirmed by analysts at Northland Securities. The firm currently has a $140.00 price target on the stock, down from their previous price target of $150.00.

Rapid7 (NASDAQ:RPD) had its outperform rating reiterated by analysts at Royal Bank of Canada. They currently have a $50.00 target price on the stock.

Surgery Partners (NASDAQ:SGRY) had its outperform rating reaffirmed by analysts at Royal Bank of Canada. The firm currently has a $49.00 target price on the stock.

Similarweb (NYSE:SMWB) had its overweight rating reiterated by analysts at Cantor Fitzgerald. They currently have a $10.00 target price on the stock.

Suncor Energy (TSE:SU) (NYSE:SU) was upgraded by analysts at TD Securities from a hold rating to a buy rating. They currently have C$59.00 target price on the stock.

Suncor Energy (TSE:SU) (NYSE:SU) was upgraded by analysts at BMO Capital Markets from a market perform rating to an outperform rating. BMO Capital Markets currently has C$62.00 price target on the stock.

Summit Materials (NYSE:SUM) had its sector perform rating reiterated by analysts at Royal Bank of Canada. Royal Bank of Canada currently has a $45.00 target price on the stock.

TransDigm Group (NYSE:TDG) had its outperform rating reissued by analysts at Royal Bank of Canada. They currently have a $1,500.00 price target on the stock.

Toast (NYSE:TOST) had its sector perform rating reiterated by analysts at Royal Bank of Canada. They currently have a $27.00 target price on the stock.

Trimble (NASDAQ:TRMB) had its outperform rating reissued by analysts at Oppenheimer Holdings Inc.. The firm currently has a $72.00 price target on the stock.

Zai Lab (NASDAQ:ZLAB) had its overweight rating reiterated by analysts at Cantor Fitzgerald.

Receive News & Ratings for Amgen Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amgen Inc and related companies with MarketBeat.com's FREE daily email newsletter.